바로가기메뉴

본문 바로가기 주메뉴 바로가기
 

logo

  • KOREAN
  • P-ISSN3022-6805
  • E-ISSN3022-6791
  • KCI

Ortho-Cellular Nutrition Therapy (OCNT) for Trigeminal Neuralgia: A Case Report

CELLMED / CELLMED, (P)3022-6805; (E)3022-6791
2025, v.15 no.12, pp.1-3
https://doi.org/10.5667/CellMed.spc.140
Jong-Bin Jo (Cellmed Hwasun Jongro Pharmacy)

Abstract

Objective: The trigeminal nerve, a cranial nerve that innervates the head and neck, supports both sensory and motor functions. Pathology affecting this nerve produces paresthesia or pain, a condition termed trigeminal neuropathy; when pain is the predominant symptom, it is referred to as trigeminal neuralgia. Trigeminal neuralgia presents with severe, paroxysmal facial pain, typically involving the jaw, gingiva, and maxilla First-line management is pharmacological; if symptoms remain refractory, surgical intervention is considered. Case Report: A Korean woman in her 50s presented with intermittent, severe pain in the maxillary region. She had been diagnosed with trigeminal neuralgia at a hospital and was taking the prescribed medication. She reported decreased concentration, anxiety, and gastrointestinal side effects. Anxiety associated with the paroxysmal pain was accompanied by fatigue and constipation. To address these symptoms, Ortho-Cellular Nutrition Therapy (OCNT), which consisted of methylsulfonylmethane (MSM), anthocyanins, selenium, zinc, magnesium, calcium, and psyllium husk, was initiated. After approximately 4 months of OCNT, the frequency and intensity of pain decreased, and her anxiety, fatigue, and constipation improved markedly. Conclusion: Appropriate OCNT may help achieve meaningful improvement in trigeminal neuralgia and its associated symptoms. However, as this case report describes a single patient, further studies are warranted before extending these findings to other patients with trigeminal neuralgia.

keywords
Ortho-Cellular Nutrition Therapy (OCNT), trigeminal neuralgia, nervous system, paroxysmal pain
Received
2025-09-26
Revised
2025-09-29
Accepted
2025-09-30
Published
2025-09-30

CELLMED